A carregar...
CAR therapy: the CD19 paradigm
Twenty-five years after its inception, the genetic engineering of T cells is now a therapeutic modality pursued at an increasing number of medical centers. This immunotherapeutic strategy is predicated on gene transfer technology to instruct T lymphocytes to recognize and reject tumor cells. Chimeri...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588281/ https://ncbi.nlm.nih.gov/pubmed/26325036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI80010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|